Two key staff members at the National Institutes of Health (NIH) are reportedly leaving the agency amid ongoing efforts by ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

The memo, penned by NIH Deputy Director for Extramural Research Michael Lauer and NIH Chief Grants Officer Michelle Bulls, ...

Researchers say it would hurt facilities that work on medical issues such as cancer research and heart disease. Elon Musk ...

Of course the effects will vary across research institutions, as institutions differ markedly in their operating models and ...

A federal judge in Boston has ordered a temporary pause nationwide on plans by the National Institutes of Health (NIH) to ...

We urge the NIH to honor its current funding commitments. The future of American biomedical research is too important to do anything less.

National Institutes of Health slashed overhead costs allowed under its grants to match private foundations, but the two don't ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

Scientists are worried about the future of the nation’s health if these cuts, now being challenged in court, are enacted.

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...